nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Thiotepa—urinary bladder cancer	0.0629	0.386	CbGbCtD
Rifabutin—CYP1A2—Fluorouracil—urinary bladder cancer	0.039	0.239	CbGbCtD
Rifabutin—CYP1A2—Etoposide—urinary bladder cancer	0.0326	0.2	CbGbCtD
Rifabutin—HSP90B1—prostate gland—urinary bladder cancer	0.018	0.0841	CbGeAlD
Rifabutin—CYP3A4—Etoposide—urinary bladder cancer	0.0171	0.105	CbGbCtD
Rifabutin—HSP90B1—seminal vesicle—urinary bladder cancer	0.0152	0.0711	CbGeAlD
Rifabutin—HSP90B1—epithelium—urinary bladder cancer	0.0132	0.0618	CbGeAlD
Rifabutin—HSP90AA1—prostate gland—urinary bladder cancer	0.0132	0.0615	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—urinary bladder cancer	0.0127	0.0595	CbGeAlD
Rifabutin—HSP90B1—renal system—urinary bladder cancer	0.0123	0.0573	CbGeAlD
Rifabutin—HSP90B1—urethra—urinary bladder cancer	0.012	0.0563	CbGeAlD
Rifabutin—CYP1A2—urine—urinary bladder cancer	0.0119	0.0554	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0116	0.0713	CbGbCtD
Rifabutin—HSP90AA1—seminal vesicle—urinary bladder cancer	0.0111	0.052	CbGeAlD
Rifabutin—HSP90B1—female reproductive system—urinary bladder cancer	0.00982	0.0459	CbGeAlD
Rifabutin—HSP90AA1—epithelium—urinary bladder cancer	0.00967	0.0452	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—urinary bladder cancer	0.00932	0.0435	CbGeAlD
Rifabutin—HSP90AA1—renal system—urinary bladder cancer	0.00897	0.0419	CbGeAlD
Rifabutin—HSP90B1—vagina—urinary bladder cancer	0.00888	0.0415	CbGeAlD
Rifabutin—HSP90AA1—urethra—urinary bladder cancer	0.00881	0.0412	CbGeAlD
Rifabutin—CYP3A4—urine—urinary bladder cancer	0.00858	0.0401	CbGeAlD
Rifabutin—HSP90AA1—female reproductive system—urinary bladder cancer	0.00718	0.0336	CbGeAlD
Rifabutin—HSP90AA1—vagina—urinary bladder cancer	0.0065	0.0304	CbGeAlD
Rifabutin—HSP90B1—lymph node—urinary bladder cancer	0.00575	0.0269	CbGeAlD
Rifabutin—HSP90AA1—lymph node—urinary bladder cancer	0.0042	0.0196	CbGeAlD
Rifabutin—CYP1A2—renal system—urinary bladder cancer	0.0029	0.0135	CbGeAlD
Rifabutin—CYP3A4—renal system—urinary bladder cancer	0.0021	0.00981	CbGeAlD
Rifabutin—CYP3A4—female reproductive system—urinary bladder cancer	0.00168	0.00785	CbGeAlD
Rifabutin—Convulsion—Fluorouracil—urinary bladder cancer	0.000716	0.00231	CcSEcCtD
Rifabutin—Chest pain—Gemcitabine—urinary bladder cancer	0.000716	0.00231	CcSEcCtD
Rifabutin—Myalgia—Gemcitabine—urinary bladder cancer	0.000716	0.00231	CcSEcCtD
Rifabutin—Arthralgia—Gemcitabine—urinary bladder cancer	0.000716	0.00231	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.000711	0.0023	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000711	0.0023	CcSEcCtD
Rifabutin—Decreased appetite—Thiotepa—urinary bladder cancer	0.000709	0.00229	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000704	0.00228	CcSEcCtD
Rifabutin—Chest pain—Fluorouracil—urinary bladder cancer	0.000704	0.00227	CcSEcCtD
Rifabutin—Myalgia—Fluorouracil—urinary bladder cancer	0.000704	0.00227	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—urinary bladder cancer	0.000703	0.00227	CcSEcCtD
Rifabutin—Leukopenia—Cisplatin—urinary bladder cancer	0.000702	0.00227	CcSEcCtD
Rifabutin—Pain—Thiotepa—urinary bladder cancer	0.000698	0.00225	CcSEcCtD
Rifabutin—Confusional state—Fluorouracil—urinary bladder cancer	0.00068	0.0022	CcSEcCtD
Rifabutin—Convulsion—Cisplatin—urinary bladder cancer	0.000679	0.00219	CcSEcCtD
Rifabutin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000672	0.00217	CcSEcCtD
Rifabutin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000672	0.00217	CcSEcCtD
Rifabutin—Myalgia—Cisplatin—urinary bladder cancer	0.000667	0.00216	CcSEcCtD
Rifabutin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000667	0.00216	CcSEcCtD
Rifabutin—Skin disorder—Gemcitabine—urinary bladder cancer	0.000667	0.00215	CcSEcCtD
Rifabutin—Anaemia—Etoposide—urinary bladder cancer	0.000664	0.00214	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000663	0.00214	CcSEcCtD
Rifabutin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000661	0.00213	CcSEcCtD
Rifabutin—Anorexia—Gemcitabine—urinary bladder cancer	0.000654	0.00211	CcSEcCtD
Rifabutin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000645	0.00208	CcSEcCtD
Rifabutin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000645	0.00208	CcSEcCtD
Rifabutin—Anorexia—Fluorouracil—urinary bladder cancer	0.000643	0.00208	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—urinary bladder cancer	0.000643	0.00208	CcSEcCtD
Rifabutin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000626	0.00202	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000625	0.00202	CcSEcCtD
Rifabutin—Convulsion—Etoposide—urinary bladder cancer	0.000622	0.00201	CcSEcCtD
Rifabutin—Skin disorder—Cisplatin—urinary bladder cancer	0.000621	0.00201	CcSEcCtD
Rifabutin—Insomnia—Gemcitabine—urinary bladder cancer	0.000621	0.00201	CcSEcCtD
Rifabutin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000616	0.00199	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000615	0.00199	CcSEcCtD
Rifabutin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000612	0.00198	CcSEcCtD
Rifabutin—Chest pain—Etoposide—urinary bladder cancer	0.000611	0.00197	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—urinary bladder cancer	0.000611	0.00197	CcSEcCtD
Rifabutin—Insomnia—Fluorouracil—urinary bladder cancer	0.00061	0.00197	CcSEcCtD
Rifabutin—Anorexia—Cisplatin—urinary bladder cancer	0.00061	0.00197	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000607	0.00196	CcSEcCtD
Rifabutin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000606	0.00196	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000602	0.00194	CcSEcCtD
Rifabutin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000602	0.00194	CcSEcCtD
Rifabutin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000601	0.00194	CcSEcCtD
Rifabutin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000597	0.00193	CcSEcCtD
Rifabutin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000594	0.00192	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000593	0.00191	CcSEcCtD
Rifabutin—Confusional state—Etoposide—urinary bladder cancer	0.000591	0.00191	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00059	0.0019	CcSEcCtD
Rifabutin—Pain—Gemcitabine—urinary bladder cancer	0.000587	0.0019	CcSEcCtD
Rifabutin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000587	0.00189	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—urinary bladder cancer	0.000586	0.00189	CcSEcCtD
Rifabutin—Asthenia—Thiotepa—urinary bladder cancer	0.000585	0.00189	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000583	0.00188	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000583	0.00188	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—urinary bladder cancer	0.000577	0.00186	CcSEcCtD
Rifabutin—Pruritus—Thiotepa—urinary bladder cancer	0.000577	0.00186	CcSEcCtD
Rifabutin—Pain—Fluorouracil—urinary bladder cancer	0.000577	0.00186	CcSEcCtD
Rifabutin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000574	0.00186	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000574	0.00185	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—urinary bladder cancer	0.000572	0.00185	CcSEcCtD
Rifabutin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00057	0.00184	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—urinary bladder cancer	0.000569	0.00184	CcSEcCtD
Rifabutin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000566	0.00183	CcSEcCtD
Rifabutin—Anorexia—Etoposide—urinary bladder cancer	0.000559	0.0018	CcSEcCtD
Rifabutin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000558	0.0018	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000557	0.0018	CcSEcCtD
Rifabutin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000556	0.0018	CcSEcCtD
Rifabutin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000556	0.0018	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000552	0.00178	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—urinary bladder cancer	0.000549	0.00177	CcSEcCtD
Rifabutin—Pain—Cisplatin—urinary bladder cancer	0.000547	0.00177	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000545	0.00176	CcSEcCtD
Rifabutin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000543	0.00175	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—urinary bladder cancer	0.00054	0.00175	CcSEcCtD
Rifabutin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000533	0.00172	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000529	0.00171	CcSEcCtD
Rifabutin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000527	0.0017	CcSEcCtD
Rifabutin—Paraesthesia—Etoposide—urinary bladder cancer	0.000526	0.0017	CcSEcCtD
Rifabutin—Dyspnoea—Etoposide—urinary bladder cancer	0.000523	0.00169	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000521	0.00168	CcSEcCtD
Rifabutin—Vomiting—Thiotepa—urinary bladder cancer	0.000519	0.00168	CcSEcCtD
Rifabutin—Rash—Thiotepa—urinary bladder cancer	0.000514	0.00166	CcSEcCtD
Rifabutin—Dermatitis—Thiotepa—urinary bladder cancer	0.000514	0.00166	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000514	0.00166	CcSEcCtD
Rifabutin—Headache—Thiotepa—urinary bladder cancer	0.000511	0.00165	CcSEcCtD
Rifabutin—Decreased appetite—Etoposide—urinary bladder cancer	0.000509	0.00165	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000508	0.00164	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000506	0.00163	CcSEcCtD
Rifabutin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000506	0.00163	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—urinary bladder cancer	0.000502	0.00162	CcSEcCtD
Rifabutin—Pain—Etoposide—urinary bladder cancer	0.000501	0.00162	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—urinary bladder cancer	0.0005	0.00161	CcSEcCtD
Rifabutin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000497	0.00161	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—urinary bladder cancer	0.000494	0.0016	CcSEcCtD
Rifabutin—Asthenia—Gemcitabine—urinary bladder cancer	0.000492	0.00159	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000487	0.00157	CcSEcCtD
Rifabutin—Pruritus—Gemcitabine—urinary bladder cancer	0.000486	0.00157	CcSEcCtD
Rifabutin—Nausea—Thiotepa—urinary bladder cancer	0.000485	0.00157	CcSEcCtD
Rifabutin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000483	0.00156	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000481	0.00155	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000479	0.00155	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—urinary bladder cancer	0.000477	0.00154	CcSEcCtD
Rifabutin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000471	0.00152	CcSEcCtD
Rifabutin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00047	0.00152	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—urinary bladder cancer	0.000465	0.0015	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—urinary bladder cancer	0.000463	0.0015	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—urinary bladder cancer	0.000463	0.0015	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—urinary bladder cancer	0.000462	0.00149	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—urinary bladder cancer	0.000462	0.00149	CcSEcCtD
Rifabutin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000462	0.00149	CcSEcCtD
Rifabutin—Asthenia—Cisplatin—urinary bladder cancer	0.000459	0.00148	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000454	0.00147	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000451	0.00146	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000446	0.00144	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000445	0.00144	CcSEcCtD
Rifabutin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000438	0.00141	CcSEcCtD
Rifabutin—Vomiting—Gemcitabine—urinary bladder cancer	0.000436	0.00141	CcSEcCtD
Rifabutin—Rash—Gemcitabine—urinary bladder cancer	0.000433	0.0014	CcSEcCtD
Rifabutin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000432	0.0014	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—urinary bladder cancer	0.000432	0.0014	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000432	0.00139	CcSEcCtD
Rifabutin—Headache—Gemcitabine—urinary bladder cancer	0.00043	0.00139	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—urinary bladder cancer	0.000429	0.00139	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000428	0.00138	CcSEcCtD
Rifabutin—Rash—Fluorouracil—urinary bladder cancer	0.000425	0.00137	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000425	0.00137	CcSEcCtD
Rifabutin—Headache—Fluorouracil—urinary bladder cancer	0.000423	0.00137	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000421	0.00136	CcSEcCtD
Rifabutin—Asthenia—Etoposide—urinary bladder cancer	0.00042	0.00136	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00042	0.00136	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000418	0.00135	CcSEcCtD
Rifabutin—Pruritus—Etoposide—urinary bladder cancer	0.000415	0.00134	CcSEcCtD
Rifabutin—Nausea—Gemcitabine—urinary bladder cancer	0.000408	0.00132	CcSEcCtD
Rifabutin—Vomiting—Cisplatin—urinary bladder cancer	0.000407	0.00131	CcSEcCtD
Rifabutin—Rash—Cisplatin—urinary bladder cancer	0.000403	0.0013	CcSEcCtD
Rifabutin—Dermatitis—Cisplatin—urinary bladder cancer	0.000403	0.0013	CcSEcCtD
Rifabutin—Diarrhoea—Etoposide—urinary bladder cancer	0.000401	0.0013	CcSEcCtD
Rifabutin—Nausea—Fluorouracil—urinary bladder cancer	0.000401	0.00129	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—urinary bladder cancer	0.0004	0.00129	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—urinary bladder cancer	0.000398	0.00128	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—urinary bladder cancer	0.000397	0.00128	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000394	0.00127	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000386	0.00125	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—urinary bladder cancer	0.000385	0.00124	CcSEcCtD
Rifabutin—Nausea—Cisplatin—urinary bladder cancer	0.00038	0.00123	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—urinary bladder cancer	0.000373	0.0012	CcSEcCtD
Rifabutin—Vomiting—Etoposide—urinary bladder cancer	0.000373	0.0012	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—urinary bladder cancer	0.000372	0.0012	CcSEcCtD
Rifabutin—Rash—Etoposide—urinary bladder cancer	0.00037	0.00119	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—urinary bladder cancer	0.000369	0.00119	CcSEcCtD
Rifabutin—Headache—Etoposide—urinary bladder cancer	0.000367	0.00119	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—urinary bladder cancer	0.000367	0.00119	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—urinary bladder cancer	0.000366	0.00118	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—urinary bladder cancer	0.000366	0.00118	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—urinary bladder cancer	0.000366	0.00118	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000365	0.00118	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000364	0.00117	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—urinary bladder cancer	0.00036	0.00116	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—urinary bladder cancer	0.000354	0.00114	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—urinary bladder cancer	0.000349	0.00113	CcSEcCtD
Rifabutin—Nausea—Etoposide—urinary bladder cancer	0.000348	0.00112	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—urinary bladder cancer	0.000344	0.00111	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000344	0.00111	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—urinary bladder cancer	0.000343	0.00111	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—urinary bladder cancer	0.000343	0.00111	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—urinary bladder cancer	0.000343	0.00111	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—urinary bladder cancer	0.000341	0.0011	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00034	0.0011	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—urinary bladder cancer	0.000335	0.00108	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000333	0.00108	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—urinary bladder cancer	0.000331	0.00107	CcSEcCtD
Rifabutin—Shock—Epirubicin—urinary bladder cancer	0.000323	0.00104	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—urinary bladder cancer	0.000323	0.00104	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000322	0.00104	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00032	0.00103	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—urinary bladder cancer	0.000319	0.00103	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—urinary bladder cancer	0.000318	0.00103	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—urinary bladder cancer	0.000317	0.00102	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000317	0.00102	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—urinary bladder cancer	0.000317	0.00102	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000315	0.00102	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000315	0.00102	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—urinary bladder cancer	0.000313	0.00101	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000313	0.00101	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000309	0.000998	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—urinary bladder cancer	0.000306	0.00099	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000305	0.000986	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000303	0.000979	CcSEcCtD
Rifabutin—Pain—Methotrexate—urinary bladder cancer	0.0003	0.00097	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000299	0.000967	CcSEcCtD
Rifabutin—Shock—Doxorubicin—urinary bladder cancer	0.000299	0.000966	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000298	0.000961	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—urinary bladder cancer	0.000297	0.00096	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000295	0.000954	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000295	0.000953	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000293	0.000946	CcSEcCtD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000293	0.000935	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—S100B—urinary bladder cancer	0.00029	0.000927	CbGpPWpGaD
Rifabutin—Anorexia—Doxorubicin—urinary bladder cancer	0.00029	0.000936	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000289	0.000934	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000289	0.000934	CcSEcCtD
Rifabutin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000289	0.000922	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000287	0.000927	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—urinary bladder cancer	0.000287	0.000916	CbGpPWpGaD
Rifabutin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000286	0.000923	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000285	0.00091	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BIRC3—urinary bladder cancer	0.000284	0.000908	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000284	0.000916	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CCNE1—urinary bladder cancer	0.000282	0.0009	CbGpPWpGaD
Rifabutin—Pain—Epirubicin—urinary bladder cancer	0.000281	0.000907	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000278	0.000896	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000278	0.000896	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—TYMS—urinary bladder cancer	0.000277	0.000884	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000277	0.000895	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—urinary bladder cancer	0.000275	0.000888	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000273	0.000882	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—KRAS—urinary bladder cancer	0.000271	0.000866	CbGpPWpGaD
Rifabutin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000271	0.000875	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000271	0.000874	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000269	0.000859	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000269	0.000868	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CREBBP—urinary bladder cancer	0.000268	0.000857	CbGpPWpGaD
Rifabutin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000268	0.000864	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—EGFR—urinary bladder cancer	0.000267	0.000854	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000267	0.000852	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDH1—urinary bladder cancer	0.000266	0.00085	CbGpPWpGaD
Rifabutin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000264	0.000854	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—urinary bladder cancer	0.000264	0.000843	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMP—urinary bladder cancer	0.000263	0.000841	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000263	0.000839	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000262	0.000848	CcSEcCtD
Rifabutin—Pain—Doxorubicin—urinary bladder cancer	0.00026	0.00084	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—urinary bladder cancer	0.00026	0.000839	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—urinary bladder cancer	0.00026	0.000839	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000259	0.000835	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—RHOA—urinary bladder cancer	0.000258	0.000824	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—KRAS—urinary bladder cancer	0.000253	0.000806	CbGpPWpGaD
Rifabutin—Asthenia—Methotrexate—urinary bladder cancer	0.000252	0.000814	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00025	0.000809	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KRAS—urinary bladder cancer	0.000249	0.000796	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000249	0.000803	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—urinary bladder cancer	0.000248	0.000802	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000247	0.00079	CbGpPWpGaD
Rifabutin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000242	0.000782	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000242	0.000771	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TERT—urinary bladder cancer	0.000241	0.00077	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000241	0.000768	CbGpPWpGaD
Rifabutin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00024	0.000776	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00024	0.000776	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00024	0.000776	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—urinary bladder cancer	0.000239	0.000763	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NAT2—urinary bladder cancer	0.000238	0.00076	CbGpPWpGaD
Rifabutin—Asthenia—Epirubicin—urinary bladder cancer	0.000236	0.000761	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000234	0.000748	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000234	0.000748	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RBX1—urinary bladder cancer	0.000233	0.000745	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CDK4—urinary bladder cancer	0.000233	0.000745	CbGpPWpGaD
Rifabutin—Pruritus—Epirubicin—urinary bladder cancer	0.000232	0.000751	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—urinary bladder cancer	0.00023	0.000736	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EP300—urinary bladder cancer	0.000229	0.000731	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO2—urinary bladder cancer	0.000227	0.000726	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000227	0.000725	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000226	0.000722	CbGpPWpGaD
Rifabutin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000225	0.000726	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ERBB2—urinary bladder cancer	0.000225	0.000717	CbGpPWpGaD
Rifabutin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000224	0.000723	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—urinary bladder cancer	0.000223	0.000721	CcSEcCtD
Rifabutin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000223	0.000712	CbGpPWpGaD
Rifabutin—Rash—Methotrexate—urinary bladder cancer	0.000221	0.000715	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—urinary bladder cancer	0.000221	0.000714	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—GLI1—urinary bladder cancer	0.00022	0.000703	CbGpPWpGaD
Rifabutin—Headache—Methotrexate—urinary bladder cancer	0.00022	0.00071	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000219	0.0007	CbGpPWpGaD
Rifabutin—Asthenia—Doxorubicin—urinary bladder cancer	0.000218	0.000704	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000217	0.000693	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—ATM—urinary bladder cancer	0.000217	0.000692	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDK4—urinary bladder cancer	0.000216	0.00069	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RBX1—urinary bladder cancer	0.000216	0.000688	CbGpPWpGaD
Rifabutin—Pruritus—Doxorubicin—urinary bladder cancer	0.000215	0.000695	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HRAS—urinary bladder cancer	0.000215	0.000685	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PPARG—urinary bladder cancer	0.000212	0.000677	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—urinary bladder cancer	0.000212	0.000677	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—FGFR3—urinary bladder cancer	0.000211	0.000674	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.00021	0.000671	CbGpPWpGaD
Rifabutin—Vomiting—Epirubicin—urinary bladder cancer	0.000209	0.000675	CcSEcCtD
Rifabutin—Nausea—Methotrexate—urinary bladder cancer	0.000209	0.000674	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000208	0.000672	CcSEcCtD
Rifabutin—Rash—Epirubicin—urinary bladder cancer	0.000207	0.000669	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—urinary bladder cancer	0.000207	0.000668	CcSEcCtD
Rifabutin—Headache—Epirubicin—urinary bladder cancer	0.000206	0.000665	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—RRM2—urinary bladder cancer	0.000206	0.000656	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—urinary bladder cancer	0.000205	0.000654	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000205	0.000654	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—urinary bladder cancer	0.000204	0.00065	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CREBBP—urinary bladder cancer	0.000204	0.00065	CbGpPWpGaD
Rifabutin—Nausea—Epirubicin—urinary bladder cancer	0.000195	0.00063	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000195	0.000622	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000195	0.000622	CbGpPWpGaD
Rifabutin—Vomiting—Doxorubicin—urinary bladder cancer	0.000193	0.000624	CcSEcCtD
Rifabutin—HSP90AA1—Disease—JAG1—urinary bladder cancer	0.000193	0.000616	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDKN1A—urinary bladder cancer	0.000192	0.000613	CbGpPWpGaD
Rifabutin—Rash—Doxorubicin—urinary bladder cancer	0.000192	0.000619	CcSEcCtD
Rifabutin—HSP90B1—Immune System—PTEN—urinary bladder cancer	0.000192	0.000612	CbGpPWpGaD
Rifabutin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000191	0.000619	CcSEcCtD
Rifabutin—Headache—Doxorubicin—urinary bladder cancer	0.00019	0.000615	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—HPGDS—urinary bladder cancer	0.00019	0.000608	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ENO2—urinary bladder cancer	0.00019	0.000608	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000189	0.000605	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000189	0.000605	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—SRC—urinary bladder cancer	0.000189	0.000603	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—RB1—urinary bladder cancer	0.000188	0.0006	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—urinary bladder cancer	0.000185	0.00059	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000185	0.000589	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RHOA—urinary bladder cancer	0.000184	0.000588	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EP300—urinary bladder cancer	0.000183	0.000583	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000181	0.000577	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—urinary bladder cancer	0.000181	0.000583	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CREBBP—urinary bladder cancer	0.00018	0.000574	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA2—urinary bladder cancer	0.000179	0.000571	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SRC—urinary bladder cancer	0.000178	0.000567	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000175	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—urinary bladder cancer	0.000171	0.000544	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.00017	0.000542	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—S100B—urinary bladder cancer	0.000169	0.00054	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000169	0.00054	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000166	0.00053	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000166	0.00053	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—urinary bladder cancer	0.000166	0.000529	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—urinary bladder cancer	0.000165	0.000527	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—urinary bladder cancer	0.000164	0.000523	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000158	0.000505	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000158	0.000505	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000157	0.000503	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000157	0.000501	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—urinary bladder cancer	0.000156	0.0005	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	0.000156	0.000498	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—urinary bladder cancer	0.000156	0.000497	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000155	0.000496	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NQO1—urinary bladder cancer	0.000153	0.00049	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RBX1—urinary bladder cancer	0.000151	0.000482	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	0.000151	0.000482	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—urinary bladder cancer	0.000151	0.000481	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—urinary bladder cancer	0.000147	0.00047	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—urinary bladder cancer	0.000146	0.000467	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000145	0.000462	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—EP300—urinary bladder cancer	0.000144	0.000458	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000143	0.000456	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TSC1—urinary bladder cancer	0.000142	0.000453	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NCOR1—urinary bladder cancer	0.00014	0.000448	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—urinary bladder cancer	0.000139	0.000445	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EP300—urinary bladder cancer	0.000139	0.000443	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAG1—urinary bladder cancer	0.000135	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1A—urinary bladder cancer	0.000135	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SRC—urinary bladder cancer	0.000135	0.000431	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000133	0.000426	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—urinary bladder cancer	0.000133	0.000425	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERCC2—urinary bladder cancer	0.000132	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1A—urinary bladder cancer	0.000129	0.000411	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—urinary bladder cancer	0.000128	0.00041	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—EP300—urinary bladder cancer	0.000128	0.00041	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—urinary bladder cancer	0.000128	0.000409	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—urinary bladder cancer	0.000125	0.000399	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—urinary bladder cancer	0.000125	0.000399	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—urinary bladder cancer	0.000124	0.000396	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TERT—urinary bladder cancer	0.000124	0.000395	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGFR3—urinary bladder cancer	0.000123	0.000393	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EP300—urinary bladder cancer	0.000122	0.000391	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000122	0.000388	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00012	0.000383	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—SRC—urinary bladder cancer	0.000119	0.00038	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—urinary bladder cancer	0.000119	0.00038	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—urinary bladder cancer	0.000118	0.000377	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NCOR1—urinary bladder cancer	0.000118	0.000376	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—urinary bladder cancer	0.000118	0.000376	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR3—urinary bladder cancer	0.000114	0.000363	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPX1—urinary bladder cancer	0.000113	0.00036	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—urinary bladder cancer	0.000113	0.000359	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—urinary bladder cancer	0.000112	0.000357	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000112	0.000356	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—urinary bladder cancer	0.000112	0.000356	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ERCC2—urinary bladder cancer	0.000111	0.000353	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00011	0.000352	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—S100B—urinary bladder cancer	0.000109	0.000349	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CREBBP—urinary bladder cancer	0.000105	0.000334	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—urinary bladder cancer	0.000104	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—urinary bladder cancer	0.000104	0.000332	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—urinary bladder cancer	0.000104	0.000332	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—urinary bladder cancer	9.86e-05	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NCOR1—urinary bladder cancer	9.84e-05	0.000314	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CREBBP—urinary bladder cancer	9.67e-05	0.000309	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	9.64e-05	0.000308	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—urinary bladder cancer	9.49e-05	0.000303	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—urinary bladder cancer	9.19e-05	0.000293	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	9.14e-05	0.000292	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	9.14e-05	0.000292	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.99e-05	0.000287	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—urinary bladder cancer	8.77e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RHOA—urinary bladder cancer	8.75e-05	0.000279	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—urinary bladder cancer	8.67e-05	0.000277	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—urinary bladder cancer	8.43e-05	0.000269	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—urinary bladder cancer	8.38e-05	0.000268	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	8.36e-05	0.000267	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CREBBP—urinary bladder cancer	8.1e-05	0.000259	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—urinary bladder cancer	8.1e-05	0.000259	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR3—urinary bladder cancer	7.96e-05	0.000254	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—urinary bladder cancer	7.95e-05	0.000254	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—urinary bladder cancer	7.92e-05	0.000253	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—urinary bladder cancer	7.73e-05	0.000247	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	7.53e-05	0.00024	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—urinary bladder cancer	7.5e-05	0.000239	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—urinary bladder cancer	7.48e-05	0.000239	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.44e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EP300—urinary bladder cancer	7.13e-05	0.000228	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	7.11e-05	0.000227	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.06e-05	0.000225	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.06e-05	0.000225	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—urinary bladder cancer	6.94e-05	0.000221	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.93e-05	0.000221	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—urinary bladder cancer	6.92e-05	0.000221	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—urinary bladder cancer	6.91e-05	0.00022	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREBBP—urinary bladder cancer	6.77e-05	0.000216	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—urinary bladder cancer	6.69e-05	0.000214	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—urinary bladder cancer	6.63e-05	0.000212	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EP300—urinary bladder cancer	6.59e-05	0.00021	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.45e-05	0.000206	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—urinary bladder cancer	6.4e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RHOA—urinary bladder cancer	6.13e-05	0.000196	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—urinary bladder cancer	6.08e-05	0.000194	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.81e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—urinary bladder cancer	5.78e-05	0.000185	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—urinary bladder cancer	5.74e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—urinary bladder cancer	5.74e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—urinary bladder cancer	5.67e-05	0.000181	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—urinary bladder cancer	5.61e-05	0.000179	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.56e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	5.54e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—EP300—urinary bladder cancer	5.52e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.49e-05	0.000175	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—urinary bladder cancer	5.38e-05	0.000172	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.35e-05	0.000171	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.32e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—urinary bladder cancer	5.3e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—urinary bladder cancer	5.14e-05	0.000164	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—urinary bladder cancer	5.01e-05	0.00016	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	5.01e-05	0.00016	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—urinary bladder cancer	4.88e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—urinary bladder cancer	4.86e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.85e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—urinary bladder cancer	4.84e-05	0.000154	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EP300—urinary bladder cancer	4.61e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—urinary bladder cancer	4.51e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—urinary bladder cancer	4.48e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	4.32e-05	0.000138	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.28e-05	0.000136	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—urinary bladder cancer	4.02e-05	0.000128	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	4e-05	0.000128	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	4e-05	0.000128	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.98e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—urinary bladder cancer	3.93e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.88e-05	0.000124	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.87e-05	0.000123	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.82e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—urinary bladder cancer	3.71e-05	0.000119	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.34e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—urinary bladder cancer	3.3e-05	0.000105	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	3.23e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—urinary bladder cancer	3.16e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.13e-05	0.0001	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.09e-05	9.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.09e-05	9.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3e-05	9.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.73e-05	8.72e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.69e-05	8.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.61e-05	8.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.5e-05	7.99e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.49e-05	7.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.47e-05	7.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.47e-05	7.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.37e-05	7.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.33e-05	7.43e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.19e-05	6.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.08e-05	6.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.93e-05	6.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.91e-05	6.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.91e-05	6.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.83e-05	5.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	5.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.77e-05	5.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.7e-05	5.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.69e-05	5.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.39e-05	4.45e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.37e-05	4.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.31e-05	4.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.22e-05	3.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.16e-05	3.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	3.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.39e-06	3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.95e-06	2.86e-05	CbGpPWpGaD
